{"url_path":"/sec/dgx/8-k/2026-02-10/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-10","source_url":"https://www.sec.gov/Archives/edgar/data/1022079/0001022079-26-000005-index.html","accession_number":"0001022079-26-000005","cik":"0001022079","ticker":"DGX","issuer_name":"QUEST DIAGNOSTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022079/0001022079-26-000005-index.html","primary_entity_key":"0001022079","primary_entity_name":"QUEST DIAGNOSTICS INC"},"word_count":121,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits\n\nd. Exhibit\n\n99.1\n[Press release of Quest Diagnostics Incorporated dated February 10, 2026 announcing, among other things, its results for the](dgx123120258-kexhibit991.htm)[quarter and](dgx123120258-kexhibit991.htm)[full](dgx123120258-kexhibit991.htm)[year ended December 31, 2025.](dgx123120258-kexhibit991.htm)\n\n99.2\n[Press release of Quest Diagnostics Incorporated dated February 10, 2026, announcing the increase in its quarterly dividend and the increase in its share repurchase authorization.](dgx123120258-kexhibit992.htm)\n\n104The cover page from this current report on Form 8-K, formatted in Inline XBRL.\n\nSignature\n\n    \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nFebruary 10, 2026\n\nQUEST DIAGNOSTICS INCORPORATED\n\nBy:/s/ Sean D. Mersten\n\nSean D. Mersten\n\nVice President and Corporate Secretary"}